Literature DB >> 21901428

Oxidative stress and β-amyloid protein in Alzheimer's disease.

Zhiyou Cai1, Bin Zhao, Anna Ratka.   

Abstract

Oxidative stress has been proposed to be an important factor in the pathogenesis of Alzheimer's disease (AD) and contributed to β-amyloid (Aβ) generation. Interaction between oxidative stress and neuro-inflammation leads to Aβ generation. AD is associated with an increase in blood-brain barrier (BBB) permeability due to tight junction involvement. Oxidative stress decreases the expression of low-density lipoprotein receptor-related protein 1 and up-regulates receptor for advanced glycation end products in BBB and increases the BBB permeability, which could potentially lead to increased deposition of Aβ within AD brain. Apoptosis takes place in the pathogenesis of AD, and oxidative stress contributes to apoptosis through both extrinsic pathway and intrinsic pathway. Oxidative stress-induced apoptosis may be a potential factor to Aβ generation. Aβ generation requires two sequential cleavages of APP, with the two proteolytic enzymes: β-secretase and γ-secretase. Oxidative damage up-regulates Aβ via inducing activity of β- and γ-secretases. In this review, we will focus on the mechanism and pathway that oxidative stress contributes to Aβ generation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901428     DOI: 10.1007/s12017-011-8155-9

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  411 in total

Review 1.  Cytokines in acute and chronic inflammation.

Authors:  C A Feghali; T M Wright
Journal:  Front Biosci       Date:  1997-01-01

2.  Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.

Authors:  J K Parks; T S Smith; P A Trimmer; J P Bennett; W D Parker
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

3.  Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.

Authors:  Krystyn Z Bourne; Diana C Ferrari; Christine Lange-Dohna; Steffen Rossner; Thomas G Wood; J Regino Perez-Polo
Journal:  J Neurosci Res       Date:  2007-05-01       Impact factor: 4.164

4.  Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.

Authors:  G Mehlhorn; M Hollborn; R Schliebs
Journal:  Int J Dev Neurosci       Date:  2000 Jul-Aug       Impact factor: 2.457

5.  Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer's disease.

Authors:  Pancham Bakshi; Elaina Margenthaler; Jon Reed; Fiona Crawford; Michael Mullan
Journal:  Cytokine       Date:  2010-11-16       Impact factor: 3.861

6.  The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.

Authors:  Eun Ok Lee; Jihee Lee Kang; Young Hae Chong
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.

Authors:  Marika S Saarela; Terho Lehtimäki; Juha O Rinne; Antti Hervonen; Marja Jylhä; Matias Röyttä; Jukka-Pekka Ahonen; Kari M Mattila
Journal:  Neurosci Lett       Date:  2004-09-09       Impact factor: 3.046

Review 8.  Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease.

Authors:  Milan Fiala; Robert Veerhuis
Journal:  Exp Gerontol       Date:  2009-08-21       Impact factor: 4.032

9.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

10.  Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.

Authors:  M Q Xia; S X Qin; L J Wu; C R Mackay; B T Hyman
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  82 in total

1.  Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.

Authors:  Mohamed A Abdelmegeed; Atrayee Banerjee; Seong-Ho Yoo; Sehwan Jang; Frank J Gonzalez; Byoung-Joon Song
Journal:  J Hepatol       Date:  2012-06-02       Impact factor: 25.083

Review 2.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

Review 3.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

4.  Alterations on Na⁺,K⁺-ATPase and acetylcholinesterase activities induced by amyloid-β peptide in rat brain and GM1 ganglioside neuroprotective action.

Authors:  Fernando Kreutz; Emilene B Scherer; Andréa G K Ferreira; Fernanda Dos Santos Petry; Camila Lino Pereira; Fabiana Santana; Angela Terezinha de Souza Wyse; Christianne Gazzana Salbego; Vera Maria Treis Trindade
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

5.  Oligomerization Alters Binding Affinity Between Amyloid Beta and a Modulator of Peptide Aggregation.

Authors:  Silvia Hilt; Tatu Rojalin; Tapani Viitala; Artturi Koivuniemi; Alex Bunker; Sebastian Wachsmann Hogiu; Tamás Kálai; Kálmán Hideg; Marjo Yliperttula; John C Voss
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2017-10-10       Impact factor: 4.126

Review 6.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

7.  Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP).

Authors:  Myrta Kostomoiri; Apostolia Fragkouli; Marina Sagnou; Leandros A Skaltsounis; Maria Pelecanou; Effie C Tsilibary; Athina K Tzinia
Journal:  Cell Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.046

Review 8.  Default mode network as a potential biomarker of chemotherapy-related brain injury.

Authors:  Shelli R Kesler
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

Review 9.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

10.  Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease.

Authors:  Rui Yang; Qingjun Wang; Lianqiu Min; Rubo Sui; Jian Li; Xuewen Liu
Journal:  Neurol Sci       Date:  2012-12-11       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.